Anthony S Zannas1, Douglas R McQuoid, Martha E Payne, James R MacFall, Allison Ashley-Koch, David C Steffens, Guy G Potter, Warren D Taylor. 1. From the Department of Psychiatry and Behavioral Sciences, the Neuropsychiatric Imaging Research Laboratory, the Department of Radiology, the Center for Human Genetics, and the Department of Medicine, Duke University Medical Center, Durham, N.C.; the Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany; the Department of Psychiatry, University of Connecticut Health Sciences Center, Farmington, Conn.; and the Department of Psychiatry, Vanderbilt University Medical Center and The Geriatric Research, Education, and Clinical Center (GRECC), Department of Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, Tenn.
Abstract
OBJECTIVE: Genetic factors confer risk for neuropsychiatric phenotypes, but the polygenic etiology of these phenotypes makes identification of genetic culprits challenging. An approach to this challenge is to examine the effects of genetic variation on relevant endophenotypes, such as hippocampal volume loss. A smaller hippocampus is associated with gene variants of the renin-angiotensin system (RAS), a system implicated in vascular disease. However, no studies to date have investigated longitudinally the effects of genetic variation of RAS on the hippocampus. METHOD: The authors examined the effects of polymorphisms of AGTR1, the gene encoding angiotensin-II type 1 receptor of RAS, on longitudinal hippocampal volumes of older adults. In all, 138 older adults (age ≥60 years) were followed for an average of about 4 years. The participants underwent repeated structural MRI and comprehensive neurocognitive testing, and they were genotyped for four AGTR1 single-nucleotide polymorphisms (SNPs) with low pairwise linkage disequilibrium values and apolipoprotein E (APOE) genotype. RESULTS: Genetic variants at three AGTR1 SNPs (rs2638363, rs1492103, and rs2675511) were independently associated with accelerated hippocampal volume loss over the 4-year follow-up period in the right but not left hemisphere. Intriguingly, these AGTR1 risk alleles also predicted worse episodic memory performance but were not related to other cognitive measures. Two risk variants (rs2638363 and rs12721331) interacted with the APOE4 allele to accelerate right hippocampal volume loss. CONCLUSIONS: Risk genetic variants of the RAS may accelerate memory decline in older adults, an effect that may be conferred by accelerated hippocampal volume loss. Molecules involved in this system may hold promise as early therapeutic targets for late-life neuropsychiatric disorders.
OBJECTIVE: Genetic factors confer risk for neuropsychiatric phenotypes, but the polygenic etiology of these phenotypes makes identification of genetic culprits challenging. An approach to this challenge is to examine the effects of genetic variation on relevant endophenotypes, such as hippocampal volume loss. A smaller hippocampus is associated with gene variants of the renin-angiotensin system (RAS), a system implicated in vascular disease. However, no studies to date have investigated longitudinally the effects of genetic variation of RAS on the hippocampus. METHOD: The authors examined the effects of polymorphisms of AGTR1, the gene encoding angiotensin-II type 1 receptor of RAS, on longitudinal hippocampal volumes of older adults. In all, 138 older adults (age ≥60 years) were followed for an average of about 4 years. The participants underwent repeated structural MRI and comprehensive neurocognitive testing, and they were genotyped for four AGTR1 single-nucleotide polymorphisms (SNPs) with low pairwise linkage disequilibrium values and apolipoprotein E (APOE) genotype. RESULTS: Genetic variants at three AGTR1 SNPs (rs2638363, rs1492103, and rs2675511) were independently associated with accelerated hippocampal volume loss over the 4-year follow-up period in the right but not left hemisphere. Intriguingly, these AGTR1 risk alleles also predicted worse episodic memory performance but were not related to other cognitive measures. Two risk variants (rs2638363 and rs12721331) interacted with the APOE4 allele to accelerate right hippocampal volume loss. CONCLUSIONS: Risk genetic variants of the RAS may accelerate memory decline in older adults, an effect that may be conferred by accelerated hippocampal volume loss. Molecules involved in this system may hold promise as early therapeutic targets for late-life neuropsychiatric disorders.
Authors: E Mervaala; J Föhr; M Könönen; M Valkonen-Korhonen; P Vainio; K Partanen; J Partanen; J Tiihonen; H Viinamäki; A K Karjalainen; J Lehtonen Journal: Psychol Med Date: 2000-01 Impact factor: 7.723
Authors: Lucia A Hindorff; Susan R Heckbert; Russell Tracy; Zhonghua Tang; Bruce M Psaty; Karen L Edwards; David S Siscovick; Richard A Kronmal; Valle Nazar-Stewart Journal: Am J Hypertens Date: 2002-12 Impact factor: 2.689
Authors: Martha E Payne; Denise L Fetzer; James R MacFall; James M Provenzale; Christopher E Byrum; K Ranga R Krishnan Journal: Psychiatry Res Date: 2002-08-20 Impact factor: 3.222
Authors: J T Tschanz; K A Welsh-Bohmer; I Skoog; N West; M C Norton; B W Wyse; R Nickles; J C Breitner Journal: Neurology Date: 2000-03-28 Impact factor: 9.910
Authors: D C Steffens; C E Byrum; D R McQuoid; D L Greenberg; M E Payne; T F Blitchington; J R MacFall; K R Krishnan Journal: Biol Psychiatry Date: 2000-08-15 Impact factor: 13.382
Authors: A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts Journal: Neurology Date: 1993-08 Impact factor: 9.910
Authors: Ming-Hong Hsieh; Douglas R McQuoid; Robert M Levy; Martha E Payne; James R MacFall; David C Steffens Journal: Int J Geriatr Psychiatry Date: 2002-06 Impact factor: 3.485
Authors: Warren D Taylor; Yi Deng; Brian D Boyd; Manus J Donahue; Kimberly Albert; Maureen McHugo; Jason A Gandelman; Bennett A Landman Journal: Brain Imaging Behav Date: 2020-02 Impact factor: 3.978